N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine
Star0
Identification
- Generic Name
- N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine
- DrugBank Accession Number
- DB08086
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 379.5368
Monoisotopic: 379.283492065 - Chemical Formula
- C21H37N3O3
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UBifunctional P-450/NADPH-P450 reductase Not Available Bacillus megaterium - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
- Kingdom
- Organic compounds
- Super Class
- Organic acids and derivatives
- Class
- Carboxylic acids and derivatives
- Sub Class
- Amino acids, peptides, and analogues
- Direct Parent
- Leucine and derivatives
- Alternative Parents
- N-acyl-L-alpha-amino acids / Imidazolyl carboxylic acids and derivatives / N-substituted imidazoles / N-acyl amines / Heteroaromatic compounds / Secondary carboxylic acid amides / Monocarboxylic acids and derivatives / Carboxylic acids / Azacyclic compounds / Organopnictogen compounds show 4 more
- Substituents
- Aromatic heteromonocyclic compound / Azacycle / Azole / Carbonyl group / Carboxamide group / Carboxylic acid / Fatty acyl / Fatty amide / Heteroaromatic compound / Hydrocarbon derivative show 17 more
- Molecular Framework
- Aromatic heteromonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- PSJOKLGFODYIHJ-IBGZPJMESA-N
- InChI
- InChI=1S/C21H37N3O3/c1-18(2)16-19(21(26)27)23-20(25)12-10-8-6-4-3-5-7-9-11-14-24-15-13-22-17-24/h13,15,17-19H,3-12,14,16H2,1-2H3,(H,23,25)(H,26,27)/t19-/m0/s1
- IUPAC Name
- (2S)-2-[12-(1H-imidazol-1-yl)dodecanamido]-4-methylpentanoic acid
- SMILES
- [H][C@@](CC(C)C)(NC(=O)CCCCCCCCCCCN1C=CN=C1)C(O)=O
References
- General References
- Not Available
- External Links
- PubChem Compound
- 46937122
- PubChem Substance
- 99444557
- ChemSpider
- 25058832
- ZINC
- ZINC000053683360
- PDBe Ligand
- LEH
- PDB Entries
- 3ben
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.00654 mg/mL ALOGPS logP 4.36 ALOGPS logP 3.58 Chemaxon logS -4.8 ALOGPS pKa (Strongest Acidic) 4.26 Chemaxon pKa (Strongest Basic) 6.54 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 84.22 Å2 Chemaxon Rotatable Bond Count 16 Chemaxon Refractivity 107.23 m3·mol-1 Chemaxon Polarizability 45.12 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.8352 Blood Brain Barrier - 0.8466 Caco-2 permeable - 0.7884 P-glycoprotein substrate Substrate 0.7011 P-glycoprotein inhibitor I Non-inhibitor 0.7533 P-glycoprotein inhibitor II Non-inhibitor 0.9406 Renal organic cation transporter Non-inhibitor 0.9048 CYP450 2C9 substrate Non-substrate 0.8345 CYP450 2D6 substrate Non-substrate 0.779 CYP450 3A4 substrate Non-substrate 0.5502 CYP450 1A2 substrate Non-inhibitor 0.9462 CYP450 2C9 inhibitor Non-inhibitor 0.8425 CYP450 2D6 inhibitor Non-inhibitor 0.9569 CYP450 2C19 inhibitor Non-inhibitor 0.6865 CYP450 3A4 inhibitor Non-inhibitor 0.7984 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9531 Ames test Non AMES toxic 0.8829 Carcinogenicity Non-carcinogens 0.9231 Biodegradation Not ready biodegradable 0.651 Rat acute toxicity 2.1447 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.981 hERG inhibition (predictor II) Non-inhibitor 0.9015
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-001i-9445000000-d303caddae984f943b35 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0059-2609000000-37dce2c76c79c65812bd Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0019-9161000000-be2a458423d056881718 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-01sj-5943000000-573ead4bf8ed5e7d1ad0 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-02aa-9531000000-cb07044814dc74f584ac Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-014i-9221000000-bf60531c0775187ee2d9 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 192.2347 predictedDeepCCS 1.0 (2019) [M+H]+ 194.78502 predictedDeepCCS 1.0 (2019) [M+Na]+ 202.35545 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsBifunctional P-450/NADPH-P450 reductase
- Kind
- Protein
- Organism
- Bacillus megaterium
- Pharmacological action
- Unknown
- General Function
- Nadph-hemoprotein reductase activity
- Specific Function
- Functions as a fatty acid monooxygenase. Catalyzes hydroxylation of medium and long-chain fatty acids at omega-1, omega-2 and omega-3 positions, with optimum chain lengths of 12-16 carbons (lauric,...
- Gene Name
- cyp102A1
- Uniprot ID
- P14779
- Uniprot Name
- Bifunctional cytochrome P450/NADPH--P450 reductase
- Molecular Weight
- 117780.49 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at September 15, 2010 21:28 / Updated at June 12, 2020 16:52